NDA 215866) and chronic weight management in adults with obesity or overweight (brand name: Zepbound, FDA approval November 2023
The published case literature is small, only documenting a handful of patients in detail
Patients should contact their GP promptly or call NHS 111 if experiencing persistent vomiting (unable to keep fluids down for 24 hours), signs of dehydration, severe abdominal pain, or any symptoms causing significant concern
The NovoCare savings card can bring eligible commercially-insured patients to $0 to $25 per month, and the NovoCare Pharmacy direct cash program offers Wegovy at about $499 per month for cash-pay patients
At Good Life Meds, were committed to your well-being
Clinical studies have observed that individuals using Mounjaro experienced an average weight loss of approximately 15% to 20% of their body mass index (BMI)